Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future (2022)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1007/s40256-021-00515-4
- Subjects: DIABETES MELLITUS; DOENÇAS CARDIOVASCULARES; FATORES DE RISCO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: American journal of cardiovascular drugs
- ISSN: 1175-3277
- Volume/Número/Paginação/Ano: v. 22, n. 4, p. 363-383, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FERRARI, Filipe et al. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future. American journal of cardiovascular drugs, v. 22, n. 4, p. 363-383, 2022Tradução . . Disponível em: https://doi.org/10.1007/s40256-021-00515-4. Acesso em: 21 jan. 2026. -
APA
Ferrari, F., Scheffel, R. S., Martins, V. M., Santos Filho, R. D. dos, & Stein, R. (2022). Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future. American journal of cardiovascular drugs, 22( 4), 363-383. doi:10.1007/s40256-021-00515-4 -
NLM
Ferrari F, Scheffel RS, Martins VM, Santos Filho RD dos, Stein R. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future [Internet]. American journal of cardiovascular drugs. 2022 ; 22( 4): 363-383.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1007/s40256-021-00515-4 -
Vancouver
Ferrari F, Scheffel RS, Martins VM, Santos Filho RD dos, Stein R. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future [Internet]. American journal of cardiovascular drugs. 2022 ; 22( 4): 363-383.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1007/s40256-021-00515-4 - Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglycerid levels in the Arabian Gulf
- Testosterone: A vascular hormone? Commentary on the study of Vlachopoulos et al.
- Is there relationship between epicardial fat and cardiovascular parameters in incident kidney transplant patients?: a post-hoc analysis
- Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia Executive summary
- Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management
- Recommendations for the management of patients with familial hypercholesterolemia
- Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes
- From the President of the International Atherosclerosis Society. [Editorial]
- Angiotensinogen gene polymorphism and HDL2 are linked to coronary artery calcification in individuals with family history of early coronary disease
Informações sobre o DOI: 10.1007/s40256-021-00515-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
